Novartis Explores Virtual Reality Tools In Drug Discovery R&D

by BiopharmaTrend        Undefined

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or
Contributors are fully responsible for assuring they own any required copyright for any content they submit to This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

   4830    Comments 0
Topics: Industry Trends   

Virtual reality (VR) has been a hot topic in game industry lately, but now it finds its way to biopharmaceutical research. Novartis is exploring opportunities to leverage this new technology for the benefit of early-stage small molecule drug discovery research. Using VR researchers at Novartis are able to visualize protein targets and small molecules and explore interactions between them in a visual three-dimensional mode.

What is even more important, virtual reality technology allows for a collaborative mode when several researchers are on the same page in the virtual environment --- looking at the same objects and discussing them interactively in 3-D space. In this way, instead of showing countless slides in the presentation, a medicinal chemist can quickly convey ideas about the next molecule modifications to her colleagues via VR setting. 

Watch a video for more insights from Novartis on how they use VR technology for drug discovery R&D. 


Topics: Industry Trends   

Share this:              


There are no comments yet. You can be the first.

Leave a Reply

Your email address will not be published. Required fields are marked *